Your browser doesn't support javascript.
loading
Hexamerization of Anti-SARS CoV IgG1 Antibodies Improves Neutralization Capacity.
Pande, Kalyan; Hollingsworth, Scott A; Sam, Miranda; Gao, Qinshan; Singh, Sujata; Saha, Anasuya; Vroom, Karin; Ma, Xiaohong Shirley; Brazell, Tres; Gorman, Dan; Chen, Shi-Juan; Raoufi, Fahimeh; Bailly, Marc; Grandy, David; Sathiyamoorthy, Karthik; Zhang, Lan; Thompson, Rob; Cheng, Alan C; Fayadat-Dilman, Laurence; Geierstanger, Bernhard H; Kingsley, Laura J.
Affiliation
  • Pande K; Discovery Biologics, Merck & Co., Inc., South San Francisco, CA, United States.
  • Hollingsworth SA; Discovery Chemistry, Merck & Co., Inc., South San Francisco, CA, United States.
  • Sam M; Discovery Biologics, Merck & Co., Inc., South San Francisco, CA, United States.
  • Gao Q; Discovery Biologics, Merck & Co., Inc., South San Francisco, CA, United States.
  • Singh S; Discovery Biologics, Merck & Co., Inc., South San Francisco, CA, United States.
  • Saha A; Discovery Biologics, Merck & Co., Inc., South San Francisco, CA, United States.
  • Vroom K; Discovery Biologics, Merck & Co., Inc., South San Francisco, CA, United States.
  • Ma XS; Discovery Biologics, Merck & Co., Inc., South San Francisco, CA, United States.
  • Brazell T; Discovery Biologics, Merck & Co., Inc., South San Francisco, CA, United States.
  • Gorman D; Discovery Biologics, Merck & Co., Inc., South San Francisco, CA, United States.
  • Chen SJ; Discovery Biologics, Merck & Co., Inc., South San Francisco, CA, United States.
  • Raoufi F; Discovery Biologics, Merck & Co., Inc., South San Francisco, CA, United States.
  • Bailly M; Discovery Biologics, Merck & Co., Inc., South San Francisco, CA, United States.
  • Grandy D; Discovery Biologics, Merck & Co., Inc., South San Francisco, CA, United States.
  • Sathiyamoorthy K; Discovery Biologics, Merck & Co., Inc., South San Francisco, CA, United States.
  • Zhang L; Infectious Disease and Vaccine Discovery, Merck & Co., Inc., West Point, PA, United States.
  • Thompson R; Discovery Chemistry, Merck & Co., Inc., South San Francisco, CA, United States.
  • Cheng AC; Discovery Chemistry, Merck & Co., Inc., South San Francisco, CA, United States.
  • Fayadat-Dilman L; Discovery Biologics, Merck & Co., Inc., South San Francisco, CA, United States.
  • Geierstanger BH; Discovery Biologics, Merck & Co., Inc., South San Francisco, CA, United States.
  • Kingsley LJ; Discovery Biologics, Merck & Co., Inc., South San Francisco, CA, United States.
Front Immunol ; 13: 864775, 2022.
Article in En | MEDLINE | ID: mdl-35603164
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: United States Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: United States Country of publication: Switzerland